-
1
-
-
0032403122
-
Anti-insulin antibodies and birthweight in pregnancies complicated by diabetes
-
Weiss PA, Kainer F, Purstner P, Zehetleitner G, Huttner U, Haas J. Anti-insulin antibodies and birthweight in pregnancies complicated by diabetes. Early Hum Dev 1998;53:145-154.
-
(1998)
Early Hum Dev
, vol.53
, pp. 145-154
-
-
Weiss, P.A.1
Kainer, F.2
Purstner, P.3
Zehetleitner, G.4
Huttner, U.5
Haas, J.6
-
2
-
-
0034849797
-
Rapid and long-acting analogues as an approach to improve insulin therapy: An evidence-based medicine assessment
-
Heise T, Heinemann L: Rapid and long-acting analogues as an approach to improve insulin therapy: An evidence-based medicine assessment. Curr Pharm Des 2001;7:1303-1325.
-
(2001)
Curr Pharm des
, Issue.7
, pp. 1303-1325
-
-
Heise, T.1
Heinemann, L.2
-
3
-
-
0036836782
-
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus
-
Persson B, Swahn ML, Hjertberg R, Hanson U, Nord E, Nordlander E, Hansson LO: Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract 2002;58:115-121.
-
(2002)
Diabetes Res Clin Pract
, vol.58
, pp. 115-121
-
-
Persson, B.1
Swahn, M.L.2
Hjertberg, R.3
Hanson, U.4
Nord, E.5
Nordlander, E.6
Hansson, L.O.7
-
4
-
-
20444394776
-
Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy
-
Wyatt JW, Frias JL, Hoyme HE, Jovanovic L, Kaaja R, Brown F, Garg S, Lee-Parritz A, Seely EW, Kerr L, Mattoo V, Tan M, IONS study group. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med. 2005;22(6):803-807.
-
(2005)
Diabet Med
, vol.22
, Issue.6
, pp. 803-807
-
-
Wyatt, J.W.1
Frias, J.L.2
Hoyme, H.E.3
Jovanovic, L.4
Kaaja, R.5
Brown, F.6
Garg, S.7
Lee-Parritz, A.8
Seely, E.W.9
Kerr, L.10
Mattoo, V.11
Tan, M.12
-
5
-
-
0032925801
-
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy (Letter)
-
Kitzmiller JL, Main E, Ward B, Theiss T, Petereson DL: Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy (Letter). Diabetes Care 1999;22:874-876.
-
(1999)
Diabetes Care
, vol.22
, pp. 874-876
-
-
Kitzmiller, J.L.1
Main, E.2
Ward, B.3
Theiss, T.4
Petereson, D.L.5
-
6
-
-
0041402823
-
Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro
-
Looukovaara S, Immonen I, Teramo KA, Kaaja R. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro. Diabetes Care 2003;26:1193-1198.
-
(2003)
Diabetes Care
, vol.26
, pp. 1193-1198
-
-
Looukovaara, S.1
Immonen, I.2
Teramo, K.A.3
Kaaja, R.4
-
7
-
-
0032862473
-
Metabolic and immunologic effects of insulin lispro in gestational diabetes
-
Jovanovic L, Ilic S, Petitt DJ, Hugo K, Gutierrez M, Browsher RR, Bastyr EJ: Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-1427.
-
(1999)
Diabetes Care
, vol.22
, pp. 1422-1427
-
-
Jovanovic, L.1
Ilic, S.2
Petitt, D.J.3
Hugo, K.4
Gutierrez, M.5
Browsher, R.R.6
Bastyr, E.J.7
-
8
-
-
34147093269
-
Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women
-
Elisabeth R. Mathiesen, Brendan Kinsley, Stephanie A. Amiel, Simon Heller, David McCance, Santiago Duran, Shannon Bellaire, Anne Raben on behalf of the Insulin Aspart Pregnancy Study Group: Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 30:771-776.
-
Diabetes Care
, vol.30
, pp. 771-776
-
-
Elisabeth, R.1
Klinsley, M.B.2
Amiel, S.A.3
Heller, S.4
McCance, D.5
Duran, S.6
Bellaire, S.7
Raben, A.8
-
9
-
-
84892796840
-
No increase in insulin antibodies and no clear evidence of transfer of insulin aspart across the placenta in pregnant women with type 1 diabetes
-
David McCance D, Damm P, Mathiesen ER, Kaaja K, Dunne F, Hod M, Jensen LE, Mersebach H. No increase in insulin antibodies and no clear evidence of transfer of insulin aspart across the placenta in pregnant women with type 1 diabetes. Abstrakt ADA 2007.
-
(2007)
Abstrakt ADA
-
-
David McCance, D.1
Damm, P.2
Mathiesen, E.R.3
Kaaja, K.4
Dunne, F.5
Hod, M.6
Jensen, L.E.7
Mersebach, H.8
-
10
-
-
0342657181
-
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
-
Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T: Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999-1005.
-
(2000)
Diabetes
, vol.49
, pp. 999-1005
-
-
Kurtzhals, P.1
Schaffer, L.2
Sorensen, A.3
Kristensen, C.4
Jonassen, I.5
Schmid, C.6
Trub, T.7
-
11
-
-
33646339424
-
Use of insulin glargine during pregnancy in seven type 1 diabetic women
-
Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diabetes Care 2006;29:471-472.
-
(2006)
Diabetes Care
, vol.29
, pp. 471-472
-
-
Woolderink, J.M.1
Van Loon, A.J.2
Storms, F.3
De Heide, L.4
Hoogenberg, K.5
-
12
-
-
0042370162
-
Use of antidiabetic agents in pregnancy: Current practise and controversy
-
Slocum JM, Soso MEB: Use of antidiabetic agents in pregnancy: Current practise and controversy. J Perinat Neonatal Nurs 2002:16:40-53.
-
(2002)
J Perinat Neonatal Nurs
, vol.16
, pp. 40-53
-
-
Slocum, J.M.1
Soso, M.E.B.2
-
14
-
-
0034687440
-
A comparison of glyburide and insulin in women with gestationel diabetes mellitus
-
Langer O, Conway DL, Berkus M, Xenakis EMJ, Gonsales O, et al. A comparison of glyburide and insulin in women with gestationel diabetes mellitus. NEJM 2000;343:1135-1138.
-
(2000)
NEJM
, vol.343
, pp. 1135-1138
-
-
Langer, O.1
Conway, D.L.2
Berkus, M.3
Xenakis, E.M.J.4
Gonsales, O.5
-
15
-
-
18144393121
-
Placental passage of metformin in women with polycystic ovary syndrome
-
Vanky E, et al. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril. 2005; 83: 1575-1578.
-
(2005)
Fertil Steril
, vol.83
, pp. 1575-1578
-
-
Vanky, E.1
-
16
-
-
0035145624
-
Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
-
Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001;75:310-315.
-
(2001)
Fertil Steril
, vol.75
, pp. 310-315
-
-
Vandermolen, D.T.1
Ratts, V.S.2
Evans, W.S.3
Stovall, D.W.4
Kauma, S.W.5
Nestler, J.E.6
-
18
-
-
0018777709
-
Metformin in management of pregnant insulin dependent diabetics
-
Coetzee EJ, Jackson WPU. Metformin in management of pregnant insulin dependent diabetics. Diabetologia 1979;16:241-245.
-
(1979)
Diabetologia
, vol.16
, pp. 241-245
-
-
Coetzee, E.J.1
Jackson, W.P.U.2
-
20
-
-
0036432962
-
Transfer of metformin into human milk
-
Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF: Transfer of metformin into human milk. Diabetologia 2002:45:1504-1514.
-
(2002)
Diabetologia
, vol.45
, pp. 1504-1514
-
-
Hale, T.W.1
Kristensen, J.H.2
Hackett, L.P.3
Kohan, R.4
Ilett, K.F.5
-
21
-
-
0028276630
-
Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use
-
Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin- converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994;96:451-456.
-
(1994)
Am J Med
, vol.96
, pp. 451-456
-
-
Shotan, A.1
Widerhorn, J.2
Hurst, A.3
Elkayam, U.4
-
23
-
-
33744966030
-
Major congenital malformations after first-trimester exposure to ACE inhibitors
-
Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA: Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354:2443-2451.
-
(2006)
N Engl J Med
, vol.354
, pp. 2443-2451
-
-
Cooper, W.O.1
Hernandez-Diaz, S.2
Arbogast, P.G.3
Dudley, J.A.4
Dyer, S.5
Gideon, P.S.6
Hall, K.7
Ray, W.A.8
-
24
-
-
85047699757
-
Diabetic nephropathy and pregnancy: The effect of ACE inhibitors prior to pregnancy on fetomaternal outcome
-
Hod M, van Dijk DJ, Karp M, Weintraub N, Rabinerson D, Bar J, Peled Y, Erman A, Boner G, Ovadia J. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 1995;10:2328-2333.
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 2328-2333
-
-
Hod, M.1
Van Dijk, D.J.2
Karp, M.3
Weintraub, N.4
Rabinerson, D.5
Bar, J.6
Peled, Y.7
Erman, A.8
Boner, G.9
Ovadia, J.10
-
25
-
-
33645352792
-
Reduced prevalence of preterm delivery in women with diabetes type 1 and microalbuminuria - Possible effect of early antihypertensive treatment during pregnancy
-
Nielsen LR, Muller C, Damm P, Mathiesen ER. Reduced prevalence of preterm delivery in women with diabetes type 1 and microalbuminuria - possible effect of early antihypertensive treatment during pregnancy. Diabetic Medicine 2006;23:426-431.
-
(2006)
Diabetic Medicine
, vol.23
, pp. 426-431
-
-
Nielsen, L.R.1
Muller, C.2
Damm, P.3
Mathiesen, E.R.4
-
26
-
-
0004160477
-
-
National Institutes of Health Publication No. 00-3029 Revised
-
National High Blood Pressure Education Program. National Institutes of Health Publication No. 00-3029. Revised 2000.
-
(2000)
National High Blood Pressure Education Program
-
-
-
28
-
-
0019430237
-
Captopril in human blood and breastmilk
-
Devlin RG, Fleiss PM. Captopril in human blood and breastmilk. J Clin Pharmacol 1981;21:110-113.
-
(1981)
J Clin Pharmacol
, vol.21
, pp. 110-113
-
-
Devlin, R.G.1
Fleiss, P.M.2
-
29
-
-
17744409055
-
Enalapril treatment of a nursing mother with slightly impaired renal function
-
Clin Nephrol 1991
-
Rush JE, Snyder DL, Barrish A, Hichens M: Comment on Huttunen K, Gronhagen-Riska C and Fyhrquist F, 1989. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol 31: 278. Clin Nephrol 1991;35:234.
-
(1989)
Clin Nephrol
, vol.31
, Issue.35
, pp. 278
-
-
Rush, J.E.1
Snyder, D.L.2
Barrish, A.3
Hichens, M.4
Huttunen, K.5
Gronhagen-Riska, C.6
Fyhrquist, F.7
-
30
-
-
31844441693
-
Statins: Beware during pregnancy
-
Statins: beware during pregnancy. Prescrire Int. 2006;15:18-19.
-
(2006)
Prescrire Int
, vol.15
, pp. 18-19
-
-
-
31
-
-
33645734737
-
Prevention of preeclampsia with low-dose aspirin - A systematic review and meta-analysis of the main randomized controlled trials
-
Ruano R, Fontes RS, Zugiab M: Prevention of preeclampsia with low-dose aspirin - a systematic review and meta-analysis of the main randomized controlled trials. Clinics. 2005;60:407-414.
-
(2005)
Clinics
, vol.60
, pp. 407-414
-
-
Ruano, R.1
Fontes, R.S.2
Zugiab, M.3
-
32
-
-
14644411043
-
Aspirin use during early pregnancy and the risk of congenital abnormalities: A population-based case-control study
-
Norgard B, Puho E, Czeizel AE, Skriver MV, Sorensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study: Am J Obstet Gynecol 2005;192:922-923.
-
(2005)
Am J Obstet Gynecol
, vol.192
, pp. 922-923
-
-
Norgard, B.1
Puho, E.2
Czeizel, A.E.3
Skriver, M.V.4
Sorensen, H.T.5
-
33
-
-
0036715406
-
Insulin dose during glucocorticoid treatment for foetal lung maturation in diabetic pregnancy-test of an algorithm
-
Mathiesen ER, Christensen AB, Hellmuth E, Horness P, Stage E, Damm P. Insulin dose during glucocorticoid treatment for foetal lung maturation in diabetic pregnancy-test of an algorithm. Acta Obstet Gynecol Scand 2002;81:835-839.
-
(2002)
Acta Obstet Gynecol Scand
, vol.81
, pp. 835-839
-
-
Mathiesen, E.R.1
Christensen, A.B.2
Hellmuth, E.3
Horness, P.4
Stage, E.5
Damm, P.6
-
34
-
-
0035108210
-
Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The worldwide atosiban versus beta-agonists study group
-
Worldwide Atosiban versus Beta-agonists Study Group
-
Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG 2001;108:133-142.
-
(2001)
BJOG
, vol.108
, pp. 133-142
-
-
-
35
-
-
5444267372
-
Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes
-
Ray JG, Vermeulen MJ, Meier C, Wyatt PR: Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. QJM 2004;97:651-653.
-
(2004)
QJM
, vol.97
, pp. 651-653
-
-
Ray, J.G.1
Vermeulen, M.J.2
Meier, C.3
Wyatt, P.R.4
-
36
-
-
12744254882
-
Folic acid supplementation diminishes diabetes-and glucoseinduced dysmorphogenesis in rat embryos in vivo and in vitro
-
Wentzel P, Gareskog M, Eriksson UJ: Folic acid supplementation diminishes diabetes-and glucoseinduced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 2005;54:546-553.
-
(2005)
Diabetes
, vol.54
, pp. 546-553
-
-
Wentzel, P.1
Gareskog, M.2
Eriksson, U.J.3
-
39
-
-
7044230212
-
-
World Health Organisation, 3rd Edition WHO, Geneva, Switzerland
-
World Health Organisation. Medical eligibility criteria for contraceptive use. 3rd Edition WHO, Geneva, Switzerland 2004.
-
(2004)
Medical Eligibility Criteria for Contraceptive Use
-
-
|